Cysteinyl leukotriene interactions with other mediators and with glucocorticosteroids during airway inflammation

Marc Peters-Golden, Anthony P. Sampson, William Henderson, Stephen Holgate, Mark Chang Hwa Liu, Redwan Moqbel, Hans Bisgaard, Stephen Peters, Reynold Panettieri, Qutayba Hamid

Research output: Contribution to journalArticle

Abstract

Unexpected aspects of the antiasthmatic efficacy of leukotriene modifiers and glucocorticosteroids have been observed. For both classes, the observed effects may be partially explainable on the basis of underrecognized interactions involving leukotrienes. This review examines the interactions between leukotrienes and other mediators of asthma. It details the effects of glucocorticosteroids on leukotriene synthesis and on leukocyte populations in asthmatic airways. Unexpected controller effects of the leukotriene modifiers may reflect the fact that leukotrienes and other mediators of asthma, such as TH2 cytokines, positively influence each other's generation. The ability of the leukotriene modifiers to disrupt such extensive interactions means that other relevant mediators are targeted indirectly by leukotriene blockade. Among asthma therapies, the glucocorticosteroids have numerous anti-inflammatory activities, but their effects may be unpredictable. Many processes involved in inflammation appear to escape modulation by glucocorticosteroids, including leukotriene synthesis, and leukotriene generation is among them. Understanding whether glucocorticosteroids reduce cysteinyl leukotriene levels in the airway is important in determining the clinical value of combining glucocorticosteroid therapy with leukotriene modifier therapy.

Original languageEnglish (US)
JournalThe Journal of Allergy and Clinical Immunology
Volume111
Issue number1 SUPPL.
DOIs
StatePublished - Jan 1 2003
Externally publishedYes

Fingerprint

Leukotrienes
Inflammation
Asthma
cysteinyl-leukotriene
Anti-Asthmatic Agents
Leukocytes
Anti-Inflammatory Agents
Therapeutics
Cytokines

Keywords

  • Asthmatic airway
  • Cysteinyl leukotrienes
  • Glucocorticosteroids
  • Leukocytes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Cysteinyl leukotriene interactions with other mediators and with glucocorticosteroids during airway inflammation. / Peters-Golden, Marc; Sampson, Anthony P.; Henderson, William; Holgate, Stephen; Liu, Mark Chang Hwa; Moqbel, Redwan; Bisgaard, Hans; Peters, Stephen; Panettieri, Reynold; Hamid, Qutayba.

In: The Journal of Allergy and Clinical Immunology, Vol. 111, No. 1 SUPPL., 01.01.2003.

Research output: Contribution to journalArticle

Peters-Golden, M, Sampson, AP, Henderson, W, Holgate, S, Liu, MCH, Moqbel, R, Bisgaard, H, Peters, S, Panettieri, R & Hamid, Q 2003, 'Cysteinyl leukotriene interactions with other mediators and with glucocorticosteroids during airway inflammation', The Journal of Allergy and Clinical Immunology, vol. 111, no. 1 SUPPL.. https://doi.org/10.1067/mai.2003.23
Peters-Golden, Marc ; Sampson, Anthony P. ; Henderson, William ; Holgate, Stephen ; Liu, Mark Chang Hwa ; Moqbel, Redwan ; Bisgaard, Hans ; Peters, Stephen ; Panettieri, Reynold ; Hamid, Qutayba. / Cysteinyl leukotriene interactions with other mediators and with glucocorticosteroids during airway inflammation. In: The Journal of Allergy and Clinical Immunology. 2003 ; Vol. 111, No. 1 SUPPL.
@article{8176cfe5898049f69ba1c5b8873697a0,
title = "Cysteinyl leukotriene interactions with other mediators and with glucocorticosteroids during airway inflammation",
abstract = "Unexpected aspects of the antiasthmatic efficacy of leukotriene modifiers and glucocorticosteroids have been observed. For both classes, the observed effects may be partially explainable on the basis of underrecognized interactions involving leukotrienes. This review examines the interactions between leukotrienes and other mediators of asthma. It details the effects of glucocorticosteroids on leukotriene synthesis and on leukocyte populations in asthmatic airways. Unexpected controller effects of the leukotriene modifiers may reflect the fact that leukotrienes and other mediators of asthma, such as TH2 cytokines, positively influence each other's generation. The ability of the leukotriene modifiers to disrupt such extensive interactions means that other relevant mediators are targeted indirectly by leukotriene blockade. Among asthma therapies, the glucocorticosteroids have numerous anti-inflammatory activities, but their effects may be unpredictable. Many processes involved in inflammation appear to escape modulation by glucocorticosteroids, including leukotriene synthesis, and leukotriene generation is among them. Understanding whether glucocorticosteroids reduce cysteinyl leukotriene levels in the airway is important in determining the clinical value of combining glucocorticosteroid therapy with leukotriene modifier therapy.",
keywords = "Asthmatic airway, Cysteinyl leukotrienes, Glucocorticosteroids, Leukocytes",
author = "Marc Peters-Golden and Sampson, {Anthony P.} and William Henderson and Stephen Holgate and Liu, {Mark Chang Hwa} and Redwan Moqbel and Hans Bisgaard and Stephen Peters and Reynold Panettieri and Qutayba Hamid",
year = "2003",
month = "1",
day = "1",
doi = "10.1067/mai.2003.23",
language = "English (US)",
volume = "111",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Mosby Inc.",
number = "1 SUPPL.",

}

TY - JOUR

T1 - Cysteinyl leukotriene interactions with other mediators and with glucocorticosteroids during airway inflammation

AU - Peters-Golden, Marc

AU - Sampson, Anthony P.

AU - Henderson, William

AU - Holgate, Stephen

AU - Liu, Mark Chang Hwa

AU - Moqbel, Redwan

AU - Bisgaard, Hans

AU - Peters, Stephen

AU - Panettieri, Reynold

AU - Hamid, Qutayba

PY - 2003/1/1

Y1 - 2003/1/1

N2 - Unexpected aspects of the antiasthmatic efficacy of leukotriene modifiers and glucocorticosteroids have been observed. For both classes, the observed effects may be partially explainable on the basis of underrecognized interactions involving leukotrienes. This review examines the interactions between leukotrienes and other mediators of asthma. It details the effects of glucocorticosteroids on leukotriene synthesis and on leukocyte populations in asthmatic airways. Unexpected controller effects of the leukotriene modifiers may reflect the fact that leukotrienes and other mediators of asthma, such as TH2 cytokines, positively influence each other's generation. The ability of the leukotriene modifiers to disrupt such extensive interactions means that other relevant mediators are targeted indirectly by leukotriene blockade. Among asthma therapies, the glucocorticosteroids have numerous anti-inflammatory activities, but their effects may be unpredictable. Many processes involved in inflammation appear to escape modulation by glucocorticosteroids, including leukotriene synthesis, and leukotriene generation is among them. Understanding whether glucocorticosteroids reduce cysteinyl leukotriene levels in the airway is important in determining the clinical value of combining glucocorticosteroid therapy with leukotriene modifier therapy.

AB - Unexpected aspects of the antiasthmatic efficacy of leukotriene modifiers and glucocorticosteroids have been observed. For both classes, the observed effects may be partially explainable on the basis of underrecognized interactions involving leukotrienes. This review examines the interactions between leukotrienes and other mediators of asthma. It details the effects of glucocorticosteroids on leukotriene synthesis and on leukocyte populations in asthmatic airways. Unexpected controller effects of the leukotriene modifiers may reflect the fact that leukotrienes and other mediators of asthma, such as TH2 cytokines, positively influence each other's generation. The ability of the leukotriene modifiers to disrupt such extensive interactions means that other relevant mediators are targeted indirectly by leukotriene blockade. Among asthma therapies, the glucocorticosteroids have numerous anti-inflammatory activities, but their effects may be unpredictable. Many processes involved in inflammation appear to escape modulation by glucocorticosteroids, including leukotriene synthesis, and leukotriene generation is among them. Understanding whether glucocorticosteroids reduce cysteinyl leukotriene levels in the airway is important in determining the clinical value of combining glucocorticosteroid therapy with leukotriene modifier therapy.

KW - Asthmatic airway

KW - Cysteinyl leukotrienes

KW - Glucocorticosteroids

KW - Leukocytes

UR - http://www.scopus.com/inward/record.url?scp=0037249234&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037249234&partnerID=8YFLogxK

U2 - 10.1067/mai.2003.23

DO - 10.1067/mai.2003.23

M3 - Article

C2 - 12532085

AN - SCOPUS:0037249234

VL - 111

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 1 SUPPL.

ER -